Showing results (51-60 of 422) with videos related to
Sort By:
Pageof 43
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2025
Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in GermanyCarolin Brinkmann, Richard P Baum, Tom StargardtThe Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancerR P Baum, D Hellwig, M MezzettiAnnals of Nuclear Medicine|November 8, 2022
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranosticsBarbara Hertz, Tadashi Watabe, Richard P BaumOptics Letters|June 16, 2018
Efficient middle-infrared generation in LiGaS2by simultaneous spectral broadening and difference-frequency generation: erratumB-H Chen, T Nagy, P BaumCardiology|January 1, 1995
Peripheral arterial-vascular disease in women: prevalence, prognosis, and treatmentM Gerhard, P Baum, K E RabyArchives of Dermatological Research|January 1, 1993
Ki-67 antigen expression and growth pattern of basal cell carcinomasH P Baum, I Meurer, G UntereggerActa Dermato-Venereologica|January 1, 1996
Integrin molecules: a clue to the non-metastasizing behaviour of basal cell carcinomas?H P Baum, T Schmid, J ReichrathNuklearmedizin. Nuclear Medicine|April 1, 2009
FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic reviewDirk Hellwig, Richrad P Baum, Carl KirschInternational Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1996
Leptin is cleared from the circulation primarily by the kidneyF Cumin, H P Baum, N LevensPageof 43